Vimarsana
Biggest News Aggregation in the World

Robert Crockart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Crockart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Crockart Today - Breaking & Trending Today

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg - Vimarsana News

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

Mumbai (Maharashtra) [India], March 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S

Glenmark Pharma gets ANDA nod for Lacosamide Tablets USP; stock jumps ~2.5% - Vimarsana News

Glenmark Pharma gets ANDA nod for Lacosamide Tablets USP; stock jumps ~2.5%

The company proposes to launch the product immediately.

Glenmark Pharma shares zoom 5% on receiving US FDA approval for Lacosamide Tablets - Vimarsana News

Glenmark Pharma shares zoom 5% on receiving US FDA approval for Lacosamide Tablets

The stock closed 2.50 per cent higher at Rs 455 against the previous close of Rs 443.90.

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg - Vimarsana News

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Foodamp;Drug Administration (U.S. FDA) for its Lacosamide Tablets1 U

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg - Vimarsana News

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Foodamp;Drug Administration (U.S. FDA) for its Lacosamide Tablets1 U